Koss Olinger Consulting LLC trimmed its stake in Rentokil Initial PLC (NYSE:RTO – Free Report) by 2.1% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 77,878 shares of the company’s stock after selling 1,711 shares during the quarter. Koss Olinger Consulting LLC’s holdings in Rentokil Initial were worth $1,869,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently bought and sold shares of the stock. Ethic Inc. bought a new position in Rentokil Initial in the second quarter valued at approximately $212,000. Exencial Wealth Advisors LLC grew its stake in Rentokil Initial by 6.5% in the second quarter. Exencial Wealth Advisors LLC now owns 47,919 shares of the company’s stock valued at $1,150,000 after purchasing an additional 2,934 shares in the last quarter. Vanguard Personalized Indexing Management LLC bought a new position in Rentokil Initial in the second quarter valued at approximately $317,000. IFP Advisors Inc grew its stake in Rentokil Initial by 115.5% in the second quarter. IFP Advisors Inc now owns 1,282 shares of the company’s stock valued at $31,000 after purchasing an additional 687 shares in the last quarter. Finally, Callan Family Office LLC bought a new position in Rentokil Initial in the second quarter valued at approximately $214,000. 9.91% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
RTO has been the subject of a number of analyst reports. Sanford C. Bernstein upgraded Rentokil Initial from an “underperform” rating to an “outperform” rating in a research note on Tuesday, October 7th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Rentokil Initial in a report on Monday, July 21st. Berenberg Bank raised Rentokil Initial to a “strong sell” rating in a report on Monday, September 29th. Weiss Ratings reissued a “hold (c-)” rating on shares of Rentokil Initial in a report on Saturday. Finally, Jefferies Financial Group raised Rentokil Initial to a “strong-buy” rating in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy”.
Rentokil Initial Trading Down 1.1%
RTO stock opened at $29.34 on Monday. The firm has a market capitalization of $14.82 billion, a PE ratio of 19.43, a PEG ratio of 4.58 and a beta of 0.95. Rentokil Initial PLC has a 1-year low of $19.60 and a 1-year high of $30.10. The business’s 50 day simple moving average is $25.56 and its 200 day simple moving average is $24.29.
Rentokil Initial Cuts Dividend
The company also recently declared a semi-annual dividend, which was paid on Tuesday, September 23rd. Investors of record on Friday, August 15th were paid a $0.2738 dividend. The ex-dividend date was Friday, August 15th. This represents a yield of 240.0%.
About Rentokil Initial
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Recommended Stories
- Five stocks we like better than Rentokil Initial
- Investing In Automotive Stocks
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- 3 REITs to Buy and Hold for the Long Term
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Is Landstar the Next Big Winner in Transportation Stocks?
Want to see what other hedge funds are holding RTO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rentokil Initial PLC (NYSE:RTO – Free Report).
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
